139 related articles for article (PubMed ID: 34607540)
1. miR-141-3p Promotes the Cisplatin Sensitivity of Osteosarcoma Cell through Targeting the Glutaminase [GLS]-Mediated Glutamine Metabolism.
Zhou X; Wei P; Wang X; Zhang J; Shi Y
Curr Mol Med; 2023; 23(2):177-184. PubMed ID: 34607540
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis.
Ge J; Wang B; Zhao S; Xu J
Bioengineered; 2022 Mar; 13(3):7670-7682. PubMed ID: 35313796
[TBL] [Abstract][Full Text] [Related]
3. Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis.
Liu X; Chen L; Wang T
J Chemother; 2023 Jul; 35(4):357-366. PubMed ID: 36120905
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-329-3p sensitizes osteosarcoma cells to cisplatin through suppression of glucose metabolism by targeting LDHA.
Li G; Li Y; Wang DY
Cell Biol Int; 2021 Apr; 45(4):766-774. PubMed ID: 33058436
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lncRNA NEAT1 induces dysfunction of fibroblast-like synoviocytes in rheumatoid arthritis via miRNA-338-3p-mediated regulation of glutamine metabolism.
Zhang M; Lu N; Li HJ; Guo XY; Lu L; Guo Y
J Orthop Surg Res; 2022 Sep; 17(1):401. PubMed ID: 36050752
[TBL] [Abstract][Full Text] [Related]
7. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
8. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis.
Qian CJ; Tong YY; Wang YC; Teng XS; Yao J
J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
11. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
Zhang L; Ye L; Xu Z; Jin Y; Song D
Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.
Chen Z; Wang Q; Huang L; Xu G; Hu J
Nutr Cancer; 2023; 75(8):1646-1657. PubMed ID: 37401860
[TBL] [Abstract][Full Text] [Related]
13. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
[TBL] [Abstract][Full Text] [Related]
14. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
[TBL] [Abstract][Full Text] [Related]
15. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
17. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis.
Li S; Liu F; Zheng K; Wang W; Qiu E; Pei Y; Wang S; Zhang J; Zhang X
Mol Cancer; 2021 Dec; 20(1):161. PubMed ID: 34876132
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
Yu WC; Chen HH; Qu YY; Xu CW; Yang C; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221814
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Chang X; Zhu W; Zhang H; Lian S
Clin Exp Dermatol; 2017 Aug; 42(6):614-621. PubMed ID: 28597996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
